Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: quinine sulfate attending: chief complaint: back pain and chest pressure major surgical or invasive procedure: cardiac catheterization with 2 stents to right coronary artery history of present illness: 68 y/o man with esrd s/p transplant , htn, hyperlipidemia, no prior cardiac history, presented with left shoulder pain/chest pressure to osh, found to have st segment elevation inferiorly with reciprocal anterior changes. pt transferred to for emergent cardiac catheterization, found to have a totally occluded rca--desx2 (3.0x 33mm and 3.5 x 28 mm). lad 60-70% mid, lcx 40% om1. co 5.01, ci 2.54, pcw 29, ra 6, pa 51/21, pa sat: 68%. . pt reports symptoms of upper back/posterior neck pain evening of with severe fatigue. pt went to sleep early that night, woke up with persistent fatigue and development of left shoulder pain that was later associated with chest pressure when he arrived at the osh. no orthopnea, pnd. no diaphoresis/palpitations/nausea/light-headedness. . of note, pt with recent admission for sscp . cp associated with diaphoresis/lh at rest/pain radiated to l>rue. ett/pmibi nl (); no ekg changes, ruled out by ce x3, (flat ck but trop peak 0.08) past medical history: 1. end-stage renal disease secondary to chronic glomerular nephritis s/p renal transplant in . 2. hypertension since . 3. hypertriglyceridemia. 4. gastroesophageal reflux disease. 5. gout. 6. history of atrial arrhythmia. social history: quit smoking , smoked 10 years 1ppd, no alcohol or ivda. married, lives with wife. truck driver. family history: positive for colon cancer. no kidney disease, hypertension, heart dz or diabetes. physical exam: physical exam: bp: 133/70 p: 78 rr: 16 oxygen sat: 97% on 4l nc gen: 68 y/o man. lying in bed. nad. breathing comfortably. heent: perrl, mmm neck: supple, jvd to mid jaw lungs: ctab cv: rrr s1 and s2 audible. no m/r/g abd: soft, nt, nd. positive bs, no masses peripheral: 2+ symm dp pulses bilaterally. feet cold. no cyanosis/clubbing/edema. neuro: no focal deficits. aox3. sensory intact. motor intact. pertinent results: ekg: after cath with st elevation in leads ii, iii and avf 05:46pm creat-2.0* 05:46pm ck(cpk)-403* 05:46pm ck-mb-26* mb indx-6.5* 11:59am ck(cpk)-410* 11:59am ck-mb-30* mb indx-7.3* 05:28am wbc-10.9 rbc-4.12* hgb-12.3* hct-36.0* mcv-87 mch-29.9 mchc-34.2 rdw-14.5 02:00am ck(cpk)-467* (peak) 02:00am ctropnt-6.0* . cath procedure: right heart catheterization: was performed by percutaneous entry of the left femoral vein, using a 7 french pulmonary wedge pressure catheter, advanced to the pcw position through a 7 french introducing sheath. cardiac output was measured by the fick method. left heart catheterization: was performed by percutaneous entry of the left femoral artery, using a 6 french left catheter, advanced to the ascending aorta through a 6 french introducing sheath. coronary angiography: was performed in multiple projections using a 6 french jl4 and a 6 french jr4, hockeystick; ar 2; and 1 catheter - access to rca was eventually with 1 - with manual contrast injections. percutaneous coronary revascularization was performed using placement of drug-eluting stent(s). . echo conclusions: the left atrium is moderately dilated. there is symmetric left ventricular hypertrophy. overall left ventricular systolic function is moderately depressed (ejection fraction 30-40 percent) secondary to severe hypokinesis of the inferior septum, inferior free wall, and posterior wall. right ventricular chamber size is normal. right ventricular systolic function appears depressed. the number of aortic valve leaflets cannot be determined. the aortic valve leaflets are mildly thickened. there is no aortic valve stenosis. trace aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. there is no mitral valve prolapse. trivial mitral regurgitation is seen. the left ventricular inflow pattern suggests impaired relaxation. there is no pericardial effusion. impression: inferior posterior myocardial infarct, with right ventricular infarct . post-stent echo conclusions: the left atrium is mildly dilated. there is mild symmetric left ventricular hypertrophy. there is mild regional left ventricular systolic dysfunction. overall left ventricular systolic function is mildly depressed. resting regional wall motion abnormalities include basal inferior akinesis and mid inferior hypokinesis a dn basal to mid inferolateral hypokinesis. the aortic valve leaflets are mildly thickened. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. no mitral regurgitation is seen. the left ventricular inflow pattern suggests impaired relaxation. there is a trivial/physiologic pericardial effusion. compared with the prior study (tape reviewed) of , right ventricular function now appears improved. brief hospital course: impression: 68 y/o man with h/o hyperlipidemia, esrd s/p renal transplant in , presented with left shoulder/chest pressure found to have totally occluded rca--s/p drug-eluting stent x2. 1. coronary: on admission and osh ekg, pt demonstrated findings consistent with inferior mi, was taken to cath lab with report showing a totally occluded rca, lad 60-70% mid, lcx 40% om1, and 2 drug-eluting stents were placed (3.0x 33mm and 3.5 x 28 mm). echo on admission demonstrated ejection fraction 30-40 percent secondary to severe hypokinesis of the inferior septum, inferior free wall, and posterior wall, with right ventricular systolic function appearing depressed. post cath, the pt remained on asa/plavix/statin, with an integrillin gtt. we added metoprolol. initially, an acei was held because or a rise in his creatinine, felt to occur in the setting of hypotension and hypoperfusion of the kidneys. an acei was added towards discharge, as his creatinine improved. his post-cath echo near discharge demonstrated an ef of 50-55%, with basal inferior akinesis and mid inferior hypokinesis and basal to mid inferolateral hypokinesis. compared with the prior study (tape reviewed) of , right ventricular function now appears improved. he was instructed to take all of his meds and to follow up with dr. (appt scheduled). 2. htn the patient received a beta blocker and an acei, with pressures well controlled. 3. arf secondary to hypotension and hypoperfusion, responded well to post-cath hydration with discharge creatinine at baseline. the renal transplant service with dr. saw the pt while he was admitted. we continued his outpatient transplant immunosuppressives, with cyclosporine level 84. his nephrologist was notified of this level, and upon discharge, he will continue his outpatient transplant meds at their current dosage, with diltiazem discontinued given recent cardiac events. he will continue with 12.5mg of metoprolol, which is a decreased dose in the setting of intermittent episodes of bradycardia to 38, asymptomatic. he will follow up with his pcp and nephrologist who can adjust these meds. 4. hyperlipidemia: we continued his lipitor 10mg po qd. on admission, he was started on lipitor 80mg po qd, however this was decreased after contacting his nephrologist, dr. (interaction with immunosuppressive therapy for renal transplant). 5. history of gout: we continued his allopurinol 100mg po qd. 6. anemia: discharge hct was 28.1. iron studies were ordered. he was instructed to follow up with dr. as soon as possible to check iron studies, and possible outpatient anemia workup. 7. low grade temp on day of discharge: pt had a temp of 99.6 on day of discharge, was afebrile throughout admission. no complaints. ua and urine cultures were sent, and cxr was done. cxr showed resolving rll atelectasis. he was instructed to follow up with his pcp and dr. to check these tests. he was instructed to come to the er if he develops symptoms. 8. full code discharge medications: 1. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 3. mycophenolate mofetil 500 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 4. allopurinol 100 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 5. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po q2pm (). disp:*120 tablet(s)* refills:*2* 6. nitroglycerin 0.3 mg tablet, sublingual sig: one (1) tablet, sublingual sublingual prn (as needed). disp:*30 tablet, sublingual(s)* refills:*2* 7. prednisone 5 mg tablet sig: one (1) tablet po qod (). disp:*15 tablet(s)* refills:*2* 8. lisinopril 5 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 9. cyclosporine 25 mg capsule sig: two (2) capsule po q12h (every 12 hours). disp:*120 capsule(s)* refills:*2* 10. atorvastatin calcium 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 11. toprol xl 25 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po once a day. disp:*30 tablet sustained release 24hr(s)* refills:*2* discharge disposition: home discharge diagnosis: 1. st segment elevation myocardial infarction status post 2 stents to right coronary artery 2. end stage renal disease status post kidney transplant 3. hyperlipidemia 4. history of gout discharge condition: stable. discharge instructions: if you experience chest pain, shortness of breath, jaw pain, or left arm pain with sweating, please report to the emergency room immediately. please take all of your medications. please follow up with your doctors (see information below). by no means you should stop taking aspirin and plavix (unless specifically instructed to do so by your cardiologist). please check your blood pressure tomorrow. if you have symptoms of lightheadedness or dizziness, please call your doctor right away or go to the emergency room. followup instructions: 1. provider: , md where: medical specialties phone: date/time: 9:00am 2. provider: , md where: medical specialties phone: date/time: 3:30pm 3. please also make an appointment with your primary care physician to follow up your iron studies, urinalysis, and urine culture. procedure: combined right and left heart cardiac catheterization coronary arteriography using two catheters injection or infusion of platelet inhibitor insertion of drug-eluting coronary artery stent(s) diagnoses: subendocardial infarction, initial episode of care anemia, unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension other and unspecified hyperlipidemia retention of urine, unspecified complications of transplanted kidney 

Answer: The patient is high likely exposed to